BeStock  
Markets › Compare › CGEM vs ANNX

CGEM vs ANNX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CGEM · Cullinan Therapeutics$8.89 ▼ 1.98%
ANNX · Annexon$3.10 ▼ 9.09%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6293123154184Nov 24, '25May 26, '26Nov 20, '26
  • CGEM -31.2%
  • ANNX -31.3%

Head to head

MetricCGEMANNX
Price$8.89$3.10
Change today▼ 1.98%▼ 9.09%
Market cap$577.15M$591.37M
Return, 3 months-59.3%-38.7%
Return, year to date-14.1%-38.2%
Return, 1 year-6.1%-27.4%
P/E (TTM)––
P/B2.14.1
P/E percentile vs own 5y53rd28th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+2.4%+6.7%
Gross margin––
Operating margin––
Net margin––
Return on equity-55.5%-129.6%
Analyst target vs. price+282.5%+545.2%
Analyst buy share100%100%
RSI (14)2630
30-day volatility102.2%81.2%
Max drawdown, 1 year-61.3%-55.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ANNX is the largest of the group by market value.
  • CGEM has returned the most over the past year.
  • ANNX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top